BIODYSSEY
LIVE

Serial Number

99468511

Owner

Biodyssey Therapeutics, Inc.

Attorney

Daniel P. Mullarkey

Filing Date

Oct 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BIODYSSEY Trademark

Serial Number: 99468511

BIODYSSEY is a trademark filed by Biodyssey Therapeutics, Inc. on October 29, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Biodyssey Therapeutics, Inc. (2 trademarks)

15211 Vanowen St., Suite 208
Van Nuys, CA 91405

Entity Type: 03

Trademark Details

Filing Date

October 29, 2025

Registration Date

Not Registered

Goods & Services

Scientific research; Scientific research and development in the fields of oncology, radiopharmaceuticals, and cancer treatment; Pharmaceutical research and development of new radiopharmaceutical agents; Design and testing of radiopharmaceutical drugs for cancer diagnosis and therapy for others; Laboratory research and testing in the field of nuclear medicine and targeted radiotherapy; research laboratory analysis services in the field of nuclear medicine and targeted radiotherapy; Providing scientific information in the field of biochemistry, biotechnology, pharmaceutical research and development, and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer

Pharmaceutical preparations for the treatment of cancer in the nature of anticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations for cancer treatment; diagnostic radiopharmaceutical preparations for clinical, medical and research use for treating cancer

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 20, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 29, 2025 MAFR
NEW APPLICATION ENTERED
Oct 29, 2025 NWAP